OBIO — Orchestra Biomed Holdings Balance Sheet
0.000.00%
- $249.30m
- $157.06m
- $33.48m
Annual balance sheet for Orchestra Biomed Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 8-K | 8-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 10.9 | 83.8 | 87.6 | 66.8 | 107 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.121 | 0.096 | 0.099 | 0.092 | 0.095 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 11.3 | 84.7 | 89.1 | 69.2 | 108 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.12 | 3.68 | 2.83 | 3.49 | 3.21 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 13.5 | 95.6 | 95.2 | 76.2 | 115 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.2 | 18.6 | 11.2 | 16.2 | 16.7 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 33.3 | 43 | 27.2 | 43.2 | 51.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | -19.8 | 52.5 | 68 | 33 | 63.4 |
| Total Liabilities & Shareholders' Equity | 13.5 | 95.6 | 95.2 | 76.2 | 115 |
| Total Common Shares Outstanding |